Bellevue Asset Management AG

Bellevue Asset Management is an authorized asset manager of collective investment schemes subject to regulation by the Swiss Financial Market Supervisory Authority FINMA. As such, it is in compliance with all regulatory and legal requirements placed upon managers of collective investment schemes. Bellevue Asset Management is responsible for the operating activities of BB Biotech AG and for the investment management operations of the Bellevue Funds (Lux) SICAV and other investment funds and mandates.

Bellevue Asset Management boasts a highly specialized team of more than 35 experienced analysts, portfolio managers and product experts. Its expertise and investment focus lie in the healthcare sector products successfully launched and managed since 1993 as well as in specific niche strategies for Swiss and European equities and so-called new markets.

The products and services offered by Bellevue Asset Management are tailored to the special needs of our intermediary and institutional clientele. Our broad expertise is channeled through accordingly diverse product forms and mandates.

Company headquarters are located in Kusnacht, near Zurich, Switzerland, but we also have offices to serve you in Germany, Austria and Luxembourg. Bellevue Asset Management AG is wholly owned by Bellevue Group, which is listed on the SIX Swiss Exchange.

Site internet
Adresse Seestrasse 16
CH-8700 Küsnacht
Téléphone 00 41 44 267 67 00
Immatriculation -
Identité juridique -
Autorité de tutelle FINMA (Autorité fédérale de surveillance des marchés financiers)
Numéro d'agrément - (depuis: -)
Activités Domaines d'interventions Principaux gérants
Société de Gestion
Gestion collective

Afficher l'effectif

Association professionnelle SFAMA (Swiss Funds and Asset MAnagement Association)

Outils investisseurs